William P Katt

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Medical Education

Cancer Stem Cells

Top Venues

OncoTargets and therapy

Pharmaceutical patent analyst

Future drug discovery

bioRxiv : the preprint server for biology

Cornell University

Yale University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cornell University Jun 10o 2009

United States

Research Associate :: Molecular Medicine

Education History

Yale University Sep 1o 2004 - Jun 1o 2009

United States

PHD :: Chemistry

Publications

Thuy-Tien T Nguyen, William P Katt, Richard A Cerione
Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies. Future drug discovery 4 (4) (2023)
Kai Su Greene, Annette Choi, Matthew Chen, Nianhui Yang, Ruizhi Li, Yijian Qiu, Michael J Lukey, Katherine S Rojas, Jonathan Shen, Kristin F Wilson, William P Katt, Gary R Whittaker, Richard A Cerione
Inhibiting Glutamine Metabolism Blocks Coronavirus Replication in Mammalian Cells. bioRxiv : the preprint server for biology (2023)
William P Katt, Cody Aplin, Richard A Cerione
Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives. OncoTargets and therapy 15 (2022)
William P Katt
Patents targeting the Warburg effect for cancer therapy: an interview with William P Katt. Pharmaceutical patent analyst 9 (1) (2020)